Emergency Capsule Endoscopy in Severe GI-bleeding

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01584869
Recruitment Status : Completed
First Posted : April 25, 2012
Last Update Posted : January 29, 2015
Information provided by (Responsible Party):
Technische Universität München

Brief Summary:
Primary objective: Evaluation of capsule endoscopy in the emergency setting of severe GI-Bleeding.

Condition or disease Intervention/treatment Phase
GI-bleeding Device: capsule endoscopy Phase 2 Phase 3

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Emergency Capsule Endoscopy in Severe GI-bleeding
Study Start Date : December 2011
Actual Primary Completion Date : March 2014
Actual Study Completion Date : March 2014

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: capsule endoscopy Device: capsule endoscopy

Primary Outcome Measures :
  1. the influence of capsule endoscopy on guidance of further diagnostic or therapeutic procedures. [ Time Frame: after complete recruitment ]

Secondary Outcome Measures :
  1. frequency of mid-GI-bleeding in all patients
  2. diagnostic yield [ Time Frame: after complete recruitment ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

patients with signs of severe GI-bleeding (with melena or dark bloody stool) and hemodynamic instability (defined as (pre)collapse or MAP < 80 mmHg or HR > 110) and/or drop of hemoglobin > 2g/dl/d and/or need of transfusion of minimum of 2 packed red cells

Exclusion Criteria:

missing consent form, pregnancy, origin of bleeding found in upper GI-endoscopy (e.g. blood in the stomach, ulcer, varices with signs of bleeding, mallory-weiss-tear, Angiodysplasia (with signs of bleeding), refluxesophagitis LA C or D) fresh bloody stool, known stenosis of the bowel, known site of bleeding, known inflammatory bowel disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01584869

Klinikum rechts der Isar
München, Bavaria, Germany, 81675
Sponsors and Collaborators
Technische Universität München

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Technische Universität München Identifier: NCT01584869     History of Changes
Other Study ID Numbers: 23042012
First Posted: April 25, 2012    Key Record Dates
Last Update Posted: January 29, 2015
Last Verified: January 2015

Keywords provided by Technische Universität München:
capsule endoscopy

Additional relevant MeSH terms:
Gastrointestinal Hemorrhage
Disease Attributes
Pathologic Processes
Gastrointestinal Diseases
Digestive System Diseases